The erectile dysfunction market isn't as lucrative as it once was, but that hasn't mattered much to Pfizer.
An estimated 1 in 10 men are affected by erectile dysfunction, or ED, according to the Cleveland Clinic. Viagra was the first noninvasive treatment for male impotency and opened up a previously undiscussed dialogue between men and their doctors about sexual health. In late 2017, Pfizer announced it would produce a generic version, called sildenafil, at half the cost of the brand name. The company also said at the time it would offer new discount programs and increase its copayment card discounts to make the brand version more accessible to patients.
"The data can't explain the reason behind why people take the generic over the brand, or vice versa," said Tori Marsh, data and content manager at GoodRx."But since generic Viagra is more affordable than the brand it's likely that cost is a factor here."
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
출처: ChannelNewsAsia - 🏆 6. / 66 더 많은 것을 읽으십시오 »
출처: TODAYonline - 🏆 1. / 99 더 많은 것을 읽으십시오 »
출처: ChannelNewsAsia - 🏆 6. / 66 더 많은 것을 읽으십시오 »
출처: BusinessTimes - 🏆 15. / 51 더 많은 것을 읽으십시오 »
출처: ChannelNewsAsia - 🏆 6. / 66 더 많은 것을 읽으십시오 »
China Mobile barred from the US market over espionage concernsWASHINGTON (BLOOMBERG) - China Mobile Ltd's bid to provide phone service in the US was rejected by regulators, who cited national security concerns about the company controlled by Beijing, adding more friction to fraught trade relations between the world's biggest economies.. Read more at straitstimes.com.
출처: The Straits Times - 🏆 8. / 63 더 많은 것을 읽으십시오 »
출처: ChannelNewsAsia - 🏆 6. / 66 더 많은 것을 읽으십시오 »